229
Views
5
CrossRef citations to date
0
Altmetric
Short Communication

Preceding profound deafness and co-factors promote development of endolymphatic hydrops in preliminary patients with delayed endolymphatic hydrops

, , , , , , & show all
Pages 1304-1308 | Received 12 May 2016, Accepted 13 Jun 2016, Published online: 06 Jul 2016

References

  • Fukushima M, Oya R, Akazawa H, Tsuruta Y, Inohara H. Gadolinium-enhanced inner ear magnetic resonance imaging for evaluation of delayed endolymphatic hydrops, including a bilateral case. Acta Otolaryngol 2016;136:451–5.
  • Schuknecht HF. Delayed endolymphatic hydrops. Ann Otol Rhinol Laryngol 1978;87:7438.
  • Naganawa S, Komada T, Fukatsu H, Ishigaki T, Takizawa O. Observation of contrast enhancement in the cochlear fluid space of healthy subjects using a 3D-FLAIR sequence at 3 Tesla. Eur Radiol 2006;16:733–7.
  • Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Imaging of Meniere's disease after intravenous administration of single-dose gadodiamide: utility of subtraction images with different inversion time. Magn Reson Med 2012;11:213–9.
  • Nakashima T, Naganawa S, Pyykko I, Gibson WP, Sone M, Nakata S, et al. Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl 2009;129:5–8.
  • Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngology–Head and Neck Surgery: Otolaryngol Head Neck Surg 1995;113:181–5.
  • Aoki M, Asai M, Nishihori T, Mizuta K, Ito Y, Ando K. The relevance of an elevation in the plasma vasopressin levels to the pathogenesis of Meniere's attack. J Neuroendocrinol 2007;19:901–6.
  • Komatsuzaki A, Futaki T, Harada Y, Hozawa J, Ishii T, Kamei T, et al. [Delayed endolymphatic hydrops. The guideline for standardization of diagnostic criteria in vertiginous diseases. The committee for standardization of diagnostic criteria in 16 vertiginous diseases] [in Japanese]. Equilib Res 1988;47:245–73.
  • Schuknecht HF. Pathophysiology of endolymphatic hydrops. Arch Otorhinolaryngol 1976;212:253–62.
  • Paparella MM, Mancini F. Trauma and Meniere's syndrome. Laryngoscope 1983;93:1004–12.
  • Nadol JB, Jr., Weiss AD, Parker SW. Vertigo of delayed onset after sudden deafness. Ann Otol Rhinol Laryngol 1975;84:841–6.
  • Merchant SN, Adams JC, Nadol JB. Jr., Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005;26:74–81.
  • Takeda T, Kakigi A, Saito H. Antidiuretic hormone (ADH) and endolymphatic hydrops. Acta Otolaryngol Suppl 1995;519:219–22.
  • Takeda T, Takeda S, Kitano H, Okada T, Kakigi A. Endolymphatic hydrops induced by chronic administration of vasopressin. Hear Res 2000;140:1–6.
  • Lim JS, Lange ME, Megerian CA. Serum antidiuretic hormone levels in patients with unilateral Meniere's disease. Laryngoscope 2003;113:1321–6.
  • Kitahara T, Maekawa C, Kizawa K, Horii A, Doi K. Plasma vasopressin and V2 receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops. Otol Neurotol 2009;30:8129.
  • Kasai S, Teranishi M, Katayama N, Sugiura M, Nakata S, Sone M, et al. Endolymphatic space imaging in patients with delayed endolymphatic hydrops. Acta Otolaryngol 2009;129:1169–74.
  • Gu X, Fang ZM, Liu Y, Lin SL, Han B, Zhang R, et al. Diagnostic value of three-dimensional magnetic resonance imaging of inner ear after intratympanic gadolinium injection, and clinical application of magnetic resonance imaging scoring system in patients with delayed endolymphatic hydrops. J Laryngol Otol 2014;128:53–9.
  • Yoshioka M, Naganawa S, Sone M, Nakata S, Teranishi M, Nakashima T. Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear. Otol Neurotol 2009;30:645–8.
  • Yamazaki M, Naganawa S, Tagaya M, Kawai H, Ikeda M, Sone M, et al. Comparison of contrast effect on the cochlear perilymph after intratympanic and intravenous gadolinium injection. AJNR Am J Neuroradiol 2012;33:773–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.